A regulatory filing disclosed that Quest Diagnostics has reached a deal with Goldman Sachs to buy back its company shares worth about $450 million. The transaction is set to be finalized during the third quarter of this year.
Quest Diagnostics signs $450M share-repurchase agreement
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||